MammerTyper® is an innovative molecular in vitro diagnostic test (IVD) which determines the expression status of the four most important breast cancer biomarkers ERBB2 (HER2), ESR1 (ER), PGR (PR) and MKI67 (marker of proliferation Ki-67) in a quantitative and reproducible way by means of RT-qPCR.
The RNXtract® RNA extraction kit is intended for routine clinical use for extraction and purification of total RNA from formalin-fixed and paraffin-embedded (FFPE) sample material. RNXtract® is especially suitable and recommended for the preparation of total RNA for the molecular analysis by MammaTyper®.
BÜHLMANN Laboratories AG
Baselstr. 55
4124 Schönenbuch
Switzerland
Fon: +41 61 487 12 12
Fax: +41 61 487 12 34
E-Mail: info@buhlmannlabs.ch
Social Links